Q2 FY2026 EarningsTHC Q2 FY26 results significantly beat consensus across the board, driven by a one-time $413M contract termination gain and robust volume growth. Revenue of $5.63B exceeded the $5.44B mean estimate, while GAAP EPS of $9.84 far outperformed the $5.73 mean. Operating performance remained solid with Hospital adjusted admissions up 3.2% and Ambulatory Care consolidated cases up 5.3%, partially offset by a $540M cash impact from the Conifer redemption.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Tenet Healthcare(THC) the Revenue is 5.628 B (+6.77%), Beat estimate;the EBIT is 1.089 B (+19.28%), Beat estimate;the EPS is 9.84 (+213.4%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
5.63B6.77%
5.44B3.13%
+0.19B3.64%
EBITExceed expectations
1.09B19.28%
0.93B1.92%
+0.16B17.36%
EPSExceed expectations
9.84213.38%
5.72582.32%
+4.1150131.06%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf